Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
maintenance dose
Description:
A maintenance dose is a recurring amount of medication given to sustain a previously achieved therapeutic drug level or treatment effect.
Related topics:
Pharmacogenetics and Drug Metabolism (9%),
Antibiotics Pharmacokinetics and Efficacy (9%),
Food Allergy and Anaphylaxis Research (8%)
Wikidata ID:
wiki/Q17126475
OpenAlex ID:
keywords/maintenance-dose
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
2020
·
Xueting Yao
, Fei Ye
, et al.
·
Clinical Infectious Diseases
·
2,822
PDF
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
1990
·
Ellen Frank
, D J Kupfer
, et al.
·
Archives of General Psychiatry
·
1,375
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
2009
·
Gilles Montalescot
, Stephen D Wiviott
, et al.
·
The Lancet
·
1,125
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial
2007
·
Stephen D. Wiviott
, Dietmar Trenk
, et al.
·
Circulation
·
951
Rational Intravenous Doses of Theophylline
1973
·
Paul A. Mitenko
, Richard I. Ogilvie
·
New England Journal of Medicine
·
675
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
2019
·
Branimir I. Sikic
, Nehal Lakhani
, et al.
·
Journal of Clinical Oncology
·
647
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
2006
·
Tomas Jernberg
, Christopher D. Payne
, et al.
·
European Heart Journal
·
563
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
2008
·
Gregory M. Cooper
, Julie A. Johnson
, et al.
·
Blood
·
520
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
2007
·
L. Wallentin
, C. Varenhorst
, et al.
·
European Heart Journal
·
477
PDF
Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety
2019
·
Derek K Chu
, Robert A Wood
, et al.
·
The Lancet
·
476
Preoperative Anxiety and Intraoperative Anesthetic Requirements
1999
·
Inna Maranets
, Zeev N. Kain
·
Anesthesia & Analgesia
·
466
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus
2022
·
Juan J. Gorgojo-Martínez
, Pedro Mezquita-Raya
, et al.
·
Journal of Clinical Medicine
·
423
PDF
Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment
2000
·
Janis Taube
, David Halsall
, et al.
·
Blood
·
423
Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis
2006
·
Anthony J. Frew
, Richard J. Powell
, et al.
·
Journal of Allergy and Clinical Immunology
·
395
PDF
Pharmacokinetic and Pharmacodynamic Properties of Oral Anticoagulants, Especially Phenprocoumon
1999
·
Knut-Olaf Haustein
·
Seminars in Thrombosis and Hemostasis
·
393
Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
2008
·
Elliott M. Antman
, Stephen D. Wiviott
, et al.
·
Journal of the American College of Cardiology
·
363
PDF
Home Treatment of Mild to Moderate Bleeding Episodes Using Recombinant Factor VIIa (Novoseven) in Haemophiliacs with Inhibitors
1998
·
Louis Aledort
, Diana Beardsley
, et al.
·
Thrombosis and Haemostasis
·
362
Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration
1970
·
Thomas W. Smith
, Edgar Haber
·
Journal of Clinical Investigation
·
352
PDF
Lean Body Mass as a Predictor of Drug Dosage: Implications for Drug Therapy
1994
·
Denis J. Morgan
, Kelly M. Bray
·
Clinical Pharmacokinetics
·
329
Variation in Biologic Availability of Digoxin from Four Preparations
1971
·
John Lindenbaum
, Mark H. Mellow
, et al.
·
New England Journal of Medicine
·
327
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients
2013
·
Lynda C. Schneider
, Rima Rachid
, et al.
·
Journal of Allergy and Clinical Immunology
·
320
The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo‐controlled trial
2006
·
Rene Westhovens
, David Yocum
, et al.
·
Arthritis & Rheumatism
·
319
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
2009
·
Richard C Becker
, David J Moliterno
, et al.
·
The Lancet
·
311
Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy
1995
·
Hirokazu Furuya
, Pedro Fernandez-Salguero
, et al.
·
Pharmacogenetics
·
295
Warfarin Maintenance Dosing Patterns in Clinical Practice
2005
·
David Garcia
, Susan Regan
, et al.
·
CHEST Journal
·
261
Show more works
View as search
Works count:
2,443
Citation count:
50,630
Year
Topic
Type